Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
14 January 2016
Header
Header image
From our blog

From our blog

Working Hard Toward Better Transparency (Guest blog)
14 January 2016 by Tim McGuire (Director, Global Transparency at Eli Lilly)

The very best clinical practice does not take place in a vacuum. It requires input and expertise from many groups: clinicians; patient organisations; academics; healthcare organisations; and the manufacturers of new medicines and medical technology.

Read more

From our blog

Working Together for Patients: Role of Consultancy
14 January 2016 by EFPIA

Collaboration between industry and health professionals benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives. Industry and health professionals collaborate in a range of activities from clinical research to sharing best clinical practice and exchanging information on how new medicines fit into the patient pathway. 

Read more

Videos

Video

Annual Health & Economic Benefits of Influenza Vaccination

Every year, influenza vaccination brings important health and economic benefits to individuals, governments, the economy, and society as a whole. This video shows the benefits of achieving the 75% vaccination coverage target agreed upon by the Council of the EU for the elderly and other key at risk populations. The data presented are based on a study on BMC Public Health, which can be accessed in full here.

View video

Events calendar

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

Events Calendar

Inaugural Conference of the European Institute for Innovation through Health Data (i~HD)
On 10/03/2016 (Paris, France)

This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The role of i~HD, as a not-for-profit Institute, is to provide independent governance oversight of such services now, and as these expand to connect with many more hospitals across Europe. The conference will present this platform and its pharma-led adoption programme, and detail the i~HD governance services that reflect state-of-the-art in the trustworthy re-use of health data for research. You will also learn about Europe's largest "big data" project in health: EMIF (European Medical Information Framework). The views of patients on the benefits of reusing their data for research will be presented by Mary Baker, past President of the European Brain Council, one of our keynote speakers.

For more information, please click here

Read more

Documents

From our blog

Event Report: The fourth annual regulatory policy summit, organised by the European Biopharmaceutical Enterprises (EBE) and the European Medicines Agency (EMA)
14 January 2016 (Publications)

Read more

What we are reading

What we are reading

How to minimise antibiotic resistance
14 January 2016 (The Lancet Infectious Diseases)

In July 2015, Glenn Tillotson suggested the steps needed to minimise antibiotic resistance and offered points on how to enable the plan reported by O'Neill and colleagues to be implemented in the foreseeable future. Here we draw attention to another important aspect overlooked by Tillotson: the development of a molecular method for detecting antibiotic resistant genes.

Read more

What we are reading

The UK-EU neck-and-neck debate
14 January 2016 (E!Sharp)

The United Kingdom enters 2016, with the two sides in the European Union referendum debate neck-and-neck. Every YouGov survey in the pasts four months has found that neither the “in” or “out” campaigns has established a clear lead. With the referendum likely in the year ahead, and possibly as early as June, what will break the deadlock?

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail